Christopher Davis Davis Selected Advisers
Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$410M |
| 2 |
LyondellBasell Industries
LYB
|
+$332M |
| 3 |
JBS
JBS N.V.
JBS
|
+$224M |
| 4 |
Sea Limited
SE
|
+$151M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$1.01B |
| 2 |
Darling Ingredients
DAR
|
+$131M |
| 3 |
MGM Resorts International
MGM
|
+$89.9M |
| 4 |
Teck Resources
TECK
|
+$76.8M |
| 5 |
Markel Group
MKL
|
+$64.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.86% |
| 2 | Healthcare | 16.53% |
| 3 | Communication Services | 11.84% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Energy | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Extra Space Storage
EXR
$31B
| $3.69M | 0.02% |
28,135
+180
| +0.6% | +$25.4K |
|
102
CBRE Group
CBRE
$44B
| $3.47M | 0.02% |
+25,610
| New | +$3.89M |
|
103
Crown Castle
CCI
$32.1B
| $3.41M | 0.02% |
41,920
-240
| -0.6% | -$20.7K |
|
104
CubeSmart
CUBE
$9.21B
| $3.38M | 0.02% |
92,270
+1,340
| +1% | +$51.4K |
|
105
Douglas Emmett
DEI
$1.97B
| $2.9M | 0.01% |
308,250
-1,560
| -0.5% | -$16K |
|
106
iShares S&P 500 Value ETF
IVE
$50.2B
| $2.45M | 0.01% |
11,624
-115,429
| -91% | -$25M |
|
107
TSMC
TSM
$2.17T
| $2.43M | 0.01% |
7,200
| – | – |
|
|
HPP
108
Hudson Pacific Properties
HPP
$787M
| $1.9M | 0.01% |
322,176
-1,850
| -0.6% | -$14.2K |
|
|
FRMI
109
Fermi Inc
FRMI
$3.79B
| $1.79M | 0.01% |
+305,730
| New | +$2.68M |
|
110
Crown Holdings
CCK
$13B
| $859K | ﹤0.01% |
8,570
| – | – |
|
111
Lam Research
LRCX
$393B
| $594K | ﹤0.01% |
2,780
-9,500
| -77% | -$2.12M |
|
|
JAN
112
Janus Living Inc
JAN
$7.2B
| $236K | ﹤0.01% |
+10,000
| New | +$234K |
|
|
NTST
113
NETSTREIT Corp
NTST
$2.07B
| – | – |
-189,600
| Closed | -$3.34M |
|
114
UDR
UDR
$12.1B
| – | – |
-113,280
| Closed | -$4.16M |
|
Similar funds
Christopher Davis's Q1 2026 Portfolio in Review
As of Q1 2026, Christopher Davis held 114 positions worth $21.8B, down 2.1% from $22.2B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Christopher Davis's Q1 2026 filing shows 6 new, 64 increased, 36 reduced and 2 closed positions. Its largest new stake was LyondellBasell Industries: 5,596,588 shares worth $451M. The largest sale was Applied Materials, an estimated $1.01B.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Communication Services.
- Christopher Davis's largest Q1 2026 buy was LyondellBasell Industries: 5,596,588 shares worth $451M.
- Christopher Davis added most to Cigna in Q1 2026, an estimated $410M increase.
- Christopher Davis's biggest Q1 2026 reduction was Applied Materials, cutting an estimated $1.01B.
- Christopher Davis fully exited UDR in Q1 2026, selling an estimated $4.16M.
- Christopher Davis's ten largest holdings make up 47% of its $21.8B portfolio in Q1 2026.
- Christopher Davis opened 6 new positions and closed 2 in Q1 2026.
- Christopher Davis's portfolio value fell 2.1% quarter-over-quarter to $21.8B.
Based on Davis Selected Advisers's 13F filing for Q1 2026, filed 7 May 2026.